Physician profile
Eric Willis
NPI 1477040038
$4,135.06
in general payments reported to CMS, 2019-2025
20 companies · $2,085 in 2025
The $2,085 reported for 2025 was more than what 77% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $972 · 2023: $248 · 2024: $831 · 2025: $2,085.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,091 · Education: $72.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,091.36 |
| Education | $72.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $971.70 | 2022 | |
| Abbvie INC. | $678.32 | 2023-2025 | Rinvoq, Skyrizi |
| Lilly USA, LLC | $312.23 | 2023-2025 | Ebglyss, Taltz, Olumiant |
| Ucb, INC. | $289.04 | 2024-2025 | Bimzelx |
| Pfizer INC. | $282.63 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $220.20 | 2023-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $212.07 | 2024-2025 | |
| Janssen Biotech, INC. | $209.95 | 2024-2025 | Tremfya |
| Leo Pharma INC. | $187.72 | 2024-2025 | Adbry, Spevigo, Anzupgo |
| Incyte Corporation | $134.66 | 2025 | Opzelura, Opzelura |
| Amgen INC. | $132.54 | 2025 | Otezla, Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $124.98 | 2024 | Cabtreo |
| Arcutis Biotherapeutics, INC. | $97.94 | 2024-2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $75.74 | 2025 | |
| Sun Pharmaceutical Industries INC. | $72.73 | 2024-2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.19 | 2025 | Spevigo |
| Integra Lifesciences Corporation | $24.42 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Galderma Laboratories, L.P. | $18.69 | 2025 | Nemluvio |
| Kyowa Kirin, INC. | $18.31 | 2024 | Poteligeo |
| Biofrontera INC. | $16.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.